Zheng, Jie; Wheeler, Eleanor; Pietzner, Maik; Andlauer, Till F M; Yau, Michelle S; Hartley, April E; Brumpton, Ben Michael; Rasheed, Humaira; Kemp, John P; Frysz, Monika; Robinson, Jamie; Reppe, Sjur; Prijatelj, Vid; Gautvik, Kaare M; Falk, Louise; Maerz, Winfried; Gergei, Ingrid; Peyser, Patricia A; Kavousi, Maryam; de Vries, Paul S; Miller, Clint L; Bos, Maxime; van der Laan, Sander W; Malhotra, Rajeev; Herrmann, Markus; Scharnagl, Hubert; Kleber, Marcus; Dedoussis, George; Zeggini, Eleftheria; Nethander, Maria; Ohlsson, Claes; Lorentzon, Mattias; Wareham, Nick; Langenberg, Claudia; Holmes, Michael V; Smith, George Davey; Tobias, Jonathan H
(John Wiley & Sons Inc., 2023-10)
Objective: In this study, we aimed to establish the causal effects of lowering sclerostin, target of the antiosteoporosis drug romosozumab, on atherosclerosis and its risk factors. Methods: A genome-wide association study ...